Explore
13D/13G Activist Filings
118,703 resultsSome filings may show "N/A" for ticker if the subject is a private fund, SPAC, or unlisted security.
| Filed ↓ | Ticker | Company | Filer | Form | % Owned | Shares |
|---|---|---|---|---|---|---|
| Feb 18, 2026 | CABA | Cabaletta Bio, Inc. | Millennium Management LLC | 13G | 5.3% | 5.1M |
| Feb 18, 2026 | KW | Kennedy-Wilson Holdings, Inc. | V. PREM WATSA | 13D/A | 19.9% | 31.0M |
| Feb 18, 2026 | ANGI | Angi Inc. | Pale Fire Capital SICAV a.s. | 13D | 8.3% | 3.6M |
| Feb 18, 2026 | DRMA | Dermata Therapeutics, Inc. | Armistice Capital, LLC | 13G/A | 5.0% | 54K |
| Feb 18, 2026 | BJDX | Bluejay Diagnostics, Inc. | Armistice Capital, LLC | 13G | 10.0% | 194K |
| Feb 18, 2026 | BCYC | BICYCLE THERAPEUTICS PLC | Armistice Capital, LLC | 13G | 6.5% | 3.2M |
| Feb 18, 2026 | ANRO | Alto Neuroscience, Inc. | Armistice Capital, LLC | 13G/A | 4.9% | 1.5M |
| Feb 18, 2026 | SUPN | Supernus Pharmaceuticals, Inc. | Integrated Core Strategies (US) LLC | 13G/A | 4.9% | 2.8M |
| Feb 18, 2026 | DRTTF | DIRTT Environmental Solutions Ltd. | Noll Shaun | 13D/A | 13.3% | 25.4M |
| Feb 18, 2026 | N/A | Proem Acquisition Corp I | Linden Capital L.P. | 13G | 7.2% | 960K |
| Feb 18, 2026 | N/A | Eikon Therapeutics, Inc. | Abu Dhabi Investment Authority | 13G | 5.2% | 2.8M |
| Feb 18, 2026 | N/A | Evolution Metals & Technologies Corp. | The Zeus Trust, UA dated April 15, 2025 | 13D | 70.2% | 416.4M |
| Feb 18, 2026 | BRTX | BioRestorative Therapies, Inc. | Mitchell P. Kopin | 13G | 4.1% | 922K |
| Feb 18, 2026 | SCHL | Scholastic Corporation | Iole Lucchese | 13D | 5.5% | 1.2M |
| Feb 18, 2026 | BLNE | Beeline Holdings, Inc. | Sansar Capital Master Fund, L.P. | 13G | 6.8% | 1.9M |
| Feb 18, 2026 | RHE | REGIONAL HEALTH PROPERTIES, INC | Radoff Family Foundation | 13G/A | 2.8% | 110K |
| Feb 18, 2026 | RHE | REGIONAL HEALTH PROPERTIES, INC | Radoff Family Foundation | 13G | 2.7% | 103K |
| Feb 18, 2026 | N/A | SCE Trust V | General Motors Investment Management Corporation | 13G | 6.7% | 0 |
| Feb 18, 2026 | RRGB | RED ROBIN GOURMET BURGERS INC | JCP Investment Partnership, LP | 13D/A | 4.3% | 777K |
| Feb 18, 2026 | DRTTF | DIRTT ENVIRONMENTAL SOLUTIONS LTD | 22NW Fund, LP | 13D/A | 26.0% | 50.0M |
| Feb 18, 2026 | GF | The New Germany Fund, Inc. | Saba Capital Management, L.P. | 13D/A | 15.3% | 2.5M |
| Feb 18, 2026 | PZG | Paramount Gold Nevada Corp. | Yuan Fangjian | 13G | 8.5% | 6.7M |
| Feb 18, 2026 | GLQ | Clough Global Equity Fund | Saba Capital Management, L.P. | 13D/A | 5.0% | 929K |
| Feb 18, 2026 | JOF | JAPAN SMALLER CAPITALIZATION FUND, INC. | Saba Capital Management, L.P. | 13D/A | 5.6% | 1.6M |
| Feb 18, 2026 | AFB | ALLIANCEBERNSTEIN NATIONAL MUNICIPAL INCOME FUND, INC. | Saba Capital Management, L.P. | 13D/A | 4.9% | 1.4M |
| Feb 18, 2026 | NHTC | NATURAL HEALTH TRENDS CORP | Sharng Chris Tahjiun | 13D | 5.2% | 443K |
| Feb 18, 2026 | HCAT | Health Catalyst, Inc. | Whetstone Capital Advisors, LLC | 13D/A | 8.2% | 5.8M |
| Feb 18, 2026 | VYGR | Voyager Therapeutics, Inc. | Armistice Capital, LLC | 13G/A | 7.2% | 4.0M |
| Feb 18, 2026 | ADIL | ADIAL PHARMACEUTICALS | Armistice Capital, LLC | 13G | 10.0% | 2.8M |
| Feb 18, 2026 | N/A | Ming Shing Group Holdings Ltd | Lam Chi Ming | 13D/A | 74.4% | 9.6M |
| Feb 18, 2026 | JG | Aurora Mobile Limited | PM Partners I LP | 13G | 13.2% | 9.7M |
| Feb 18, 2026 | WEN | The Wendy's Company | Nelson Peltz | 13D/A | 16.2% | 30.9M |
| Feb 18, 2026 | GSIT | GSI TECHNOLOGY INC | Galloway Capital Partners, LLC | 13D | 5.0% | 1.8M |
| Feb 18, 2026 | EWCZ | European Wax Center, Inc. | Hilary L. Shane | 13G | 6.0% | 2.7M |
| Feb 18, 2026 | ITRN | Ituran Location & Control Ltd. | Izzy Sheratzky | 13G | 19.4% | 3.9M |
| Feb 18, 2026 | ITRN | Ituran Location & Control Ltd. | Yehuda Kahane | 13G | 6.6% | 1.3M |
| Feb 18, 2026 | GIW | GigCapital8 Corp. | Lynrock Lake LP | 13G | 5.4% | 1.5M |
| Feb 18, 2026 | CYCU | Cycurion, Inc. | Armistice Capital, LLC | 13G | 10.0% | 301K |
| Feb 18, 2026 | BJDX | Bluejay Diagnostics | Armistice Capital, LLC | 13G | 10.0% | 194K |
| Feb 18, 2026 | BDRX | Biodexa Pharmaceuticals Plc | Armistice Capital, LLC | 13G | 10.0% | 284K |
| Feb 18, 2026 | MNTN | MNTN, Inc. | Mark Douglas | 13G | 17.8% | 9.6M |
| Feb 18, 2026 | ASTI | Ascent Solar Technologies, Inc. | Armistice Capital, LLC | 13G | 10.0% | 386K |
| Feb 18, 2026 | AGIO | AGIOS PHARMACEUTICALS, INC. | Armistice Capital, LLC | 13G | 5.2% | 3.0M |
| Feb 18, 2026 | AEMD | AETHLON MEDICAL INC | Armistice Capital, LLC | 13G | 10.0% | 84K |
| Feb 18, 2026 | ASNS | Actelis Networks, Inc. | Armistice Capital, LLC | 13G/A | 5.0% | 918K |
| Feb 18, 2026 | ANGO | Alto Neuroscience, Inc. | Armistice Capital, LLC | 13G/A | 6.0% | 1.6M |
| Feb 18, 2026 | CTOR | CITIUS ONCOLOGY, INC. | Armistice Capital, LLC | 13G/A | 10.0% | 8.1M |
| Feb 18, 2026 | CRIS | CURIS INC | Armistice Capital, LLC | 13G/A | 10.0% | 1.3M |
| Feb 18, 2026 | AVNS | AVANOS MEDICAL, INC. | Armistice Capital, LLC | 13G/A | 6.9% | 3.2M |
| Feb 18, 2026 | AUTL | Autolus Therapeutics plc | Armistice Capital, LLC | 13G/A | 6.6% | 17.5M |